Dlg502a/e
New Products From This Supplier
DLG502A/E is an ester-terminated Pharma / Medical Grade linear co-polymer of polycondesed DL-lactic acid and Glycolic acid OR linear co-polymer of ring-opening polymerisation of DL-lactide and Glycolide in a 50:50 molar ratio and with an inherent viscosity midpoint of 0.2 dl/g.
It is supplied in the form of white-coloured lyophilized powder.
Primarily utilized in parenteral formulations and medical devices. Its applications extend to tissue engineering, nanoparticle formulation and microsphere formulation, among other diverse uses.
CAS Number:
26780-50-7
Manufacturing Process:
Polycondensation
Molecular Formula:
(C3H4O2)m x (C2H2O2)n
Synonyms:PLGA, Poly(D,L-lactic-co-glycolic) acid, Ester terminated, Poly(DL-lactide-co-glycolide), Ester terminated
Business Nature
Manufacturer
Country/Region
Vadodara, India
Main Products
Biopolymer...
Payment Terms
Bank wire (T/T)
Nomisma Healthcare and our unwavering commitment to delivering high-quality PLGA Polymer. Our focus on continuous improvement and troubleshooting sets us apart, making us a reliable partner in the field. At Nomisma Healthcare, our innovative process ensures the production of PLGA Polymer with exceptional characteristics. Our polymer boasts a pristine snow-white appearance, precise control, and a steady molecular weight. Furthermore, the low levels of residual monomers, particularly lactide and glycolide, make our polymer an ideal choice for controlled-release formulations.
